Workflow
OK lens
icon
Search documents
爱博医疗-关键会议要点:高端化驱动增长;人工晶状体(PIOL)将成为长期增长引擎
2026-03-01 17:23
27 February 2026 | 7:02AM CST Equity Research Eyebright (688050.SS): Key meeting takeaways: Premiumization drives growth; PIOL to be the growth engine in the long run On Feb 24, we hosted an investor meeting with Eyebright's management. Below are our key takeaways. 2025 review & policy environment: In 2025, the company delivered a resilient performance despite a challenging policy backdrop. While revenue from conventional IOLs declined for the first time amid DRG implementation and VBP pressure, the overall ...